Results of phase 3 randomized trial for use of docetaxel as a radiosensitizer in patients with head and neck cancer unsuitable for cisplatin-based chemoradiation.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Vijay Maruti Patil, Vanita Noronha, Nandini Sharrel Menon, Sarbani Laskar, Ashwini Budrukkar, Monali Swain, Atanu Bhattacharjee, Arun Balaji, Pankaj Chaturvedi, Devendra A Chaukar, P. S. Pai, Sudhir Vasudevan Nair, Nilendu Purandare, Archi Agrawal, Ameya Puranik, Kavita Prakash Nawale, Vijayalakshmi Mathrudev, Kumar Prabhash
Institution: Tata Memorial Hospital
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4293083597